There is always a need to assess the benefits and risks of any drug. In the case of Tamiflu, the benefits are very considerable.
I would like to continue in English, in order to give you a more detailed answer.
I think the challenge is that we know that Tamiflu and Relenza are effective. They're not always as effective as we'd love them to be, but there isn't anything else in terms of treatment. We know they are also safe and effective in children. And the risk profile is good; in other words, the risks are low and tend to be minor. Given the choice between influenza and the potential risk of severe illness and death versus a theoretical small risk from taking an antiviral, that again would tip the balance. But again, it's still a choice; it's a clinical choice in the setting.
These studies were done on seasonal flu, not the new H1. Talking to pediatricians and others who are actually assessing and seeing these children, the reflection to me was, well, we don't have the studies yet, but they have consistently said to me that the kids who come in and get on Tamiflu earlier have done better than the kids who did not.
So in the face of that kind of experience and evidence, given the choice, particularly with moderate or severe illness, I think I would have no hesitancy about using Tamiflu in that situation.